Scientific Advisor

Dr. Teesalu is a co-discoverer of the iRGD/CendR technology. He is Professor of Nanomedicine and head of the Laboratory of Cancer Biology of the University of Tartu, Estonia (www.cancerbiology.ee) and an adjunct assistant professor at the Cancer Center, Sanford Burnham Prebys Medical Discovery Institute in La Jolla, Calif. His current research on development of precision-guided anticancer drugs is supported by prestigious grants from European Research Council, EMBO, and the Wellcome Trust Dr. Teesalu is a recipient of a Career Development Award from the Susan Komen for Cure Foundation (2011) and a recipient of the International Senior Fellowship from the Wellcome Trust (2011). Dr. Teesalu was awarded Estonian National Prize in Medicine in February 2017.